<DOC>
	<DOCNO>NCT00629239</DOCNO>
	<brief_summary>The purpose study see treatment AZD4818 four week tolerable , safe effective treating COPD , , compare placebo .</brief_summary>
	<brief_title>Tolerability/Safety Efficacy Inhaled AZD4818 Patients With Moderate Severe Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Clinical diagnosis COPD , symptom 1 year Current exsmokers smoke history least 10 packyears ( 1 packyear=20 cigarettes/day 1 year ) Lung function ( FEV1 ) 40 80 % predict normal value use short act bronchodilator Clinical suspicion active tuberculosis Any current clinically significant respiratory tract disorder COPD History current clinically relevant arrhythmia , heart block , ECG abnormality , unstable angina</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>COPD</keyword>
	<keyword>tolerability</keyword>
	<keyword>inhalation</keyword>
</DOC>